Navigation Links
Maxygen Reports Third Quarter 2007 Financial Results
Date:11/1/2007

REDWOOD CITY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY) today reported financial results for the quarter ended September 30, 2007. Maxygen reported a net loss of $14.7 million, or $0.40 per share, for the third quarter 2007 as compared to a net loss of $10.7 million, or $0.30 per share, for the comparable period in 2006. The net loss reflects continued investment in the company's lead program, MAXY-G34, for the treatment of chemotherapy-induced neutropenia.

"Our Phase II trial of MAXY-G34 in breast cancer patients is accelerating as we continue to initiate additional sites," said Russell Howard, chief executive officer of Maxygen. "We are also pleased to report that our MAXY-VII program for hemophilia is moving quickly and according to plan towards a European CTA filing in the first half of 2008."

"During the third quarter we announced a hold on our MAXY-alpha program, which is partnered with Roche," continued Dr. Howard. "We plan to provide an update on the status of this program as soon as information becomes available. Because the program is fully funded by Roche, our near-term financials are unaffected by the hold."

Excluding the impact of non-cash stock compensation expense under SFAS 123( R ), Maxygen reported a non-GAAP net loss (see Footnote A) of approximately $13.0 million, or $0.35 per share, in the third quarter of 2007, compared to a non-GAAP net loss of approximately $8.9 million, or $0.25 per share, in the third quarter of 2006.

Revenue for the third quarter of 2007 was $1.0 million, compared to $4.2 million for the same period in 2006. The decrease was primarily due to the discontinuation in the second quarter of this year of Maxygen's partnership wit
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):New science estimates carbon storage potential of US lands 2UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2University of Washington professor garners Avanti Young Investigator Award 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 1Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 2Bay Area Plastic Surgeon Reaches Out to Patients with New State of the Art Website 61595 3Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 1Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 2Bull 26apos 3Bs Eye 3A AHF 26apos 3Bs 26amp 3B 238220 3BNo Judgemental Bullsh t 26amp 3B 238221 3B HIV Testing Campaign Hits the Mark 61590 3Cleaning Up Indoor Air Quality 3A New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices 61585 1Cleaning Up Indoor Air Quality 3A New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices 61585 2Cleaning Up Indoor Air Quality 3A New Certification Standard for Cleaning Products Will Help Millions of People Make More Educated Choices 61585 3